Scroll Top

Muoio, Benson, Singleton, Greenwald, Pinkin, Downey & Sumter Bill to Boost State Response to Elevated Lead Levels in Children Gains Assembly Panel Approval

(TRENTON) – The Assembly Appropriations Committee panel on Thursday approved legislation sponsored by Assembly Democrats Elizabeth Maher Muoio, Daniel Benson, Troy Singleton, Louis Greenwald, Nancy Pinkin, Joann Downey and Shavonda Sumter to strengthen the state’s response to elevated blood lead levels in children.

“When it comes to the health and safety of our children, the CDC has essentially concluded that there are no ‘safe’ blood lead levels,” said Muoio (D-Mercer/Hunterdon). “This bill takes that into account and will boost the state’s response accordingly to help prevent more children from falling victim to a lifetime of irrevocable damage.”

The bill (A-3411) would amend current state statutes related to childhood lead poisoning by lowering the blood lead level threshold that would trigger responsive action from the state in order to make it consistent with the most recent recommendations from the federal Centers for Disease Control and Prevention (CDC).

“Even low levels of lead in blood have been shown to affect a child’s IQ, their ability to pay attention, and their overall academic achievement,” said Benson (D-Mercer/Middlesex). “Given the fact that the effects of lead exposure cannot be corrected, this bill will empower the state to act more swiftly when the smallest levels are detected.”

“What this new lower lead level means is that more children will likely be identified as having lead exposure, prompting parents, doctors, health officials, and communities to take action earlier to reduce the child’s future exposure to lead,” said Singleton (D-Burlington).

The sponsors welcomed the news that Gov. Christie has also directed the Department of Health (DOH) to follow suit, noting that their legislation will codify these changes into law so that they will not be subject to the whims of future administrations.

“Millions of children across the country are being exposed to lead in their homes, increasing their risks for damage to the brain and nervous system, slowed growth and development, and learning and behavior problems,” said Greenwald (D-Camden/Burlington). “It’s incumbent upon us to create more aggressive response protocol.”

“If it can be said that any good has come out of the crisis in Flint, it’s that it reignited the conversation on lead detection and prevention in children nationwide,” said Pinkin (D-Middlesex). “This bill turns that conversation into action and demonstrates that we, as a state, are committed to eliminating this threat.”

The CDC previously recommended that responsive action be taken to address childhood lead poisoning in those cases where a lead screening test showed an elevated blood lead level of 10 micrograms per deciliter or more – designated as a blood lead “level of concern.” However, the CDC’s Advisory Committee for Childhood Lead Poisoning Prevention issued a report in 2012 concluding that the term “level of concern” should be eliminated from all future CDC policies to reflect current data showing that there is no safe blood lead level in children.

In particular, the working group recommended that the CDC lower the benchmark for responsive action to an elevated blood lead level of only five micrograms per deciliter. The working group also recommended that the CDC take action, every four years, to update this recommended action level, as appropriate, based on the most recent data available.

“Given the fact that the CDC has acknowledged that there is no safe blood lead level in children, protecting them from exposure to lead is important to lifelong good health,” said Downey (D-Monmouth). ‘Lowering the threshold for state intervention will have a profound impact on many more children’s lives.”

“With many cities in New Jersey having children with higher lead levels than those in Flint, it’s absolutely imperative that we increase our detection and response methods,” said Sumter (D-Bergen, Passaic). “For children like those I represent in Newark, this can have a profound impact on the rest of their life.”

Although the CDC has updated its own agency recommendations on children’s blood lead levels, the state DOH has not similarly revised its regulations to this effect, and it continues to determine the necessity for responsive action based on the outdated blood lead “level of concern” of 10 micrograms per deciliter.

Therefore, this bill would revise the current state law pertaining to childhood lead poisoning by requiring the DOH to make its regulations on elevated blood lead levels consistent with the current position of the CDC. In doing so, the bill would define the term “elevated blood lead level” to mean a level of lead in the bloodstream that equals or exceeds five micrograms per deciliter, or another amount as may be identified in the most recent CDC recommendations, which necessitates the undertaking of responsive action.

The bill would expressly require the DOH’s rules and regulations regarding elevated blood lead levels to be consistent with the CDC’s recommendations, and it would further require the DOH, within 30 days after the bill’s date of enactment, and on at least a biennial basis thereafter, to review and revise these rules and regulations, in order to ensure that they comport with the latest CDC guidance on this issue.

Additionally, the bill would specify that the DOH’s public information campaign on lead screening is to: (1) highlight the importance of lead screening, and encourage parents, especially those who have not yet complied with the screening provisions of this act, to have their children screened for lead poisoning at regular intervals, in accordance with the age-based timeframes established by department regulation; and (2) provide for the widespread dissemination of information to parents and health care providers on the dangers of lead poisoning, the factors that contribute to lead poisoning, the recommended ages at which children should be tested for lead poisoning, and the elevated blood lead levels that will necessitate responsive action under this act.

If the DOH changes the elevated blood lead levels that are required for responsive action, as may be necessary to conform its regulations to federal guidance, the information disseminated through the public information campaign would need to be revised and reissued within 30 days thereafter.

The bill was approved by the Assembly Health and Senior Services Committee and now awaits final legislative approval from the full Assembly.